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A B S T R A C T   
Background: Although studies have examined the association between tobacco and cannabis use in adolescence 
with subsequent cognitive functioning, study designs are usually not able to distinguish correlation from 
causation. 
Methods: Separate patterns of tobacco and cannabis use were derived using longitudinal latent class analysis 
based on measures assessed on five occasions from age 13–18 in a large UK population cohort (Avon Longitudinal 
Study of Parents and Children). Cognitive functioning measures comprised of working memory, response inhi-
bition, and emotion recognition assessed at 24 years of age. Mendelian randomization was used to examine the 
possible causal relationship between smoking initiation, lifetime cannabis use and cognitive functioning. 
Results: We found evidence of a relationship between tobacco and cannabis use and diminished cognitive 
functioning for each of the outcomes in the observational analyses. There was evidence to suggest that late-onset 
regular tobacco smokers (b=-0.29, 95 %CI=-0.45 to -0.13), early-onset regular tobacco smokers (b=-0.45, 95 % 
CI=-0.84 to -0.05), and early-onset regular cannabis users (b=-0.62, 95 %CI=-0.93 to -0.31) showed poorer 
working memory. Early-onset regular tobacco smokers (b = 0.18, 95 %CI = 0.07 to 0.28), and early-onset regular 
cannabis users (b = 0.30, 95 %CI = 0.08 to 0.52) displayed poorer ability to inhibit responses. Late-onset regular 
(b=-0.02, 95 %CI=-0.03 to - 0.00), and early-onset regular tobacco smokers (b=-0.04, 95 %CI=-0.08 to -0.01) 
showed poorer ability to recognise emotions. Mendelian randomization analyses were imprecise and did not 
provide additional support for the observational results. 
Conclusion: There was some evidence to suggest that adolescent tobacco and cannabis use were associated with 
deficits in working memory, response inhibition and emotion recognition. Better powered genetic studies are 
required to determine whether these associations are causal.   
1. Introduction 
Tobacco and cannabis use during adolescence, when the brain is still 
developing and undergoing considerable structural and function 
changes (De Bellis et al., 2000), is a major public health concern. The 
association between adolescent tobacco and cannabis use and subse-
quent cognitive functioning has received particular attention because 
certain cognitive functions (e.g. working memory, response inhibition, 
and emotion recognition) do not peak until early adulthood (Davidson 
et al., 2006; Thomas et al., 2007) in parallel with maturation of the 
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prefrontal cortex (Sowell et al., 2001). Due to the prolonged neuro-
developmental period and the potential for the endocannabinoid and 
nicotinic cholinergic signalling systems to be involved in altering 
development (Galve-Roperh et al., 2009; Newman and McGaughy, 
2008), it is plausible that tobacco and cannabis use during this poten-
tially critical period could play a role in disrupting normal brain 
development (Dwyer et al., 2008; Jacobus and Tapert, 2014). None-
theless, there is still uncertainty regarding the nature of the association 
between tobacco and cannabis use and neurocognitive function. 
A recent review of prospective studies of the association between 
cannabis use and cognition in young people (Gonzalez et al., 2017) 
highlighted an association between cannabis use and neuropsychologi-
cal decline (Jackson et al., 2016). However, studies often fail to control 
for neurocognitive measures prior to cannabis use (Jacobus et al., 2015; 
Tait et al., 2011) and associations were largely found for the heaviest 
cannabis users and were often attenuated when potential confounders 
(e.g. other forms of substance use) were included (Jackson et al., 2016; 
Mokrysz et al., 2016b). A recent study (Meier et al., 2018), using a 
co-twin design (allowing for the disentanglement of shared genetic 
factors from non-shared environmental factors), assessed IQ prior to 
cannabis initiation and found insufficient evidence to suggest cannabis 
use was associated with decline in general IQ. Findings from two recent 
longitudinal studies of adolescents (Castellanos-Ryan et al., 2017; Morin 
et al., 2018) using a repeated measures design suggest that the associ-
ation between cognitive functioning and cannabis use could be 
bidirectional. 
The direction of association between tobacco and cognitive func-
tioning is also unclear as there is a lack of epidemiological studies that 
have prospectively examined this relationship. Evidence from animal 
studies suggests that nicotine exposure may have more deleterious 
developmental effects during adolescence, when the brain is thought to 
be more vulnerable (Slotkin, 2002). Furthermore, human studies sug-
gest that nicotine has a more potent effect when consumed in late 
adolescence compared to in adulthood (Azam et al., 2007). One small 
prospective study (n = 112, aged between 17–21 years) found that 
current smokers performed worse than non-smokers on a variety of 
cognitive assessments including language related IQ and working 
memory while controlling for earlier cognitive measures and other 
substance use (Fried et al., 2006). Finally, one large study (n~20,000) 
on Israeli male soldiers (Weiser et al., 2010) found a dose-response 
relationship between number of cigarettes smoked and lower general 
cognitive ability compared to non-smokers. They also found diminished 
cognitive functioning in individuals who started starting smoking after 
18 years of age. The literature is further complicated by the differential 
effects of acute, chronic, and withdrawal from chronic nicotine on 
cognitive functioning. Studies have reported beneficial effects of acute 
nicotine (Heishman et al., 2010), negative effects of nicotine withdrawal 
on cognitive functioning (Mendrek et al., 2006), and the reduction of 
beneficial effects with nonacute nicotine consumption as tolerance de-
velops (Jacobsen et al., 2005). 
In an effort to strengthen the evidence, we used data from the Avon 
Longitudinal Study of Parents and Children (ALSPAC), a large UK pro-
spective birth cohort, to investigate whether patterns of adolescent to-
bacco and cannabis use were prospectively associated with cognitive 
functioning at 24 years of age. Separate measures of tobacco and 
cannabis use were assessed on six occasions across adolescence allowing 
distinct classes of tobacco and cannabis use to be established. As young 
people do not initiate tobacco or cannabis at the same time (Degenhardt 
et al., 2008), we used longitudinal latent class analysis to identify 
heterogenous classes of individuals with different tobacco and cannabis 
use profiles across adolescence (Lubke and Muthén, 2005). As a next 
step we used genetic variants that are separately associated with 
smoking initiation and lifetime cannabis use to perform Mendelian 
randomization (MR) to improve causal inference (Lawlor et al., 2017). 
The aims were to investigate (1) whether separate patterns of tobacco 
smoking and cannabis use (assessed between 13–18 years) were 
associated with working memory, response inhibition, and emotion 
recognition assessed at age 24, and (2) whether tobacco use and 
cannabis use were associated with these cognitive outcomes using MR. 
2. Methods 
2.1. Observational analyses 
2.1.1. Participants and procedure 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a 
cohort born in 1991–92. ALSPAC recruited 14,541 pregnant women 
resident in Avon, UK, with expected dates of delivery between 1 April 
1991 and 31 December 1992. The initial number of pregnancies enrolled 
is 14,541 (for these at least one questionnaire has been returned or a 
“Children in Focus” clinic had been attended by 19/07/99). Of these 
initial pregnancies, there was a total of 14,676 foetuses, resulting in 
14,062 live births and 13,988 children who were alive at 1 year of age. 
When the oldest children were approximately 7 years of age, an attempt 
was made to bolster the initial sample with eligible cases who had failed 
to join the study originally. The total sample size for analyses using any 
data collected after the age of 7 years is therefore 15,454 pregnancies, 
resulting in 15,589 foetuses. Of this total sample 14,901 were alive at 1 
year of age (Boyd et al., 2013; Fraser et al., 2013; Northstone et al., 
2019). Of these, 9997 offspring were invited to attend the 24-year clinic 
assessment. A detailed overview of our study population, including 
attrition at the different measurement occasions is presented in Sup-
plementary Material Fig. S1. Detailed information about ALSPAC is 
available online www.bris.ac.uk/alspac. A fully searchable data dictio-
nary is available on the study’s website http://www.bristol.ac.uk/alsp 
ac/researchers/our-data/. Approval for the study was obtained from 
the ALSPAC Ethics and Law Committee and the Local Research Ethics 
Committees (http://www.bristol.ac.uk/alspac/researchers/research 
-ethics/). Informed consent for the use of data collected via question-
naires and clinics was obtained from participants following recom-
mendations of the ALSPAC Ethics and Law Committee at the time. 
Consent for biological samples was collected in accordance with the 
Human Tissue Act (2004). 
2.2. Measures 
A timeline of data collection is presented in Supplementary Material 
Fig. S2. 
2.2.1. Exposure variables 
Information on tobacco and cannabis use were collected on six oc-
casions via questionnaire (Q) or during attendance at a study clinic (C). 
Median ages at response were: 13y(C), 14y(Q), 15y(C) 16y(Q), 17y(C), 
and 18y(Q). 
2.2.2. Tobacco use 
Patterns of tobacco use have been described in detail elsewhere 
(Howe et al., 2017). Responses to one or more questions at each time 
point were used to derive a repeated four-level ordinal variable with 
categories ‘Non-smoker’, ‘Occasional smoker’ (typically less than once 
per week), ‘Weekly smoker’ and ‘Daily smoker’. There was good 
agreement that a four-class solution was adequate in explaining the 
heterogeneity in tobacco based on model fit criteria (see Table S1a). The 
four-class model (n = 8525) comprised individuals with a higher prob-
ability of ‘early-onset regular tobacco smokers’ (3.4 %), ‘late-onset 
regular tobacco smokers’ (11.6 %), ‘experimenters’ (17.4 %), and 
‘non-tobacco smokers’ (67.5 %) (Fig. S3a). 
2.2.3. Cannabis use 
Patterns of cannabis use have been described in detail elsewhere 
(Taylor et al., 2017). Responses to one or more questions at each time 
point were used to derive a repeated three-level ordinal variable with 
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categories ‘Do not use’, ‘Occasional use’ (typically less than once per 
week) and ‘Frequent use’ (typically once per week or more). There was 
good agreement that a four-class solution was adequate in explaining the 
heterogeneity in cannabis use based on model fit criteria (see 
Table S1b). The four-class model (n = 8093) comprised individuals with 
a higher probability of ‘early-onset regular users’ (3.6 %), ‘early-onset 
occasional users’ (2.9 %), ‘late-onset occasional users’ (13.8 %), and 
‘non-users’ (79.8 %) (Fig. S3b). 
2.2.4. Outcome variables 
At 24 years of age (M = 24.0 years; SD = 9.8 months) participants 
attended a clinic-based assessment which included computerised 
cognitive assessments as part of a broader assessment battery of mental 
and physical health and behaviour. Data collection for the online 
questionnaires was collected and managed by REDcap electronic data 
capture tools (Harris et al., 2019, 2009). Further information on all three 
cognitive tasks is presented in Supplementary material. 
2.2.5. Working memory 
The N-back task (2-back condition) was used to assess working 
memory. The N-back task (Kirchner, 1958) is widely used to measure 
working memory. A measure of discriminability (d′) was chosen as the 
primary outcome measure given it is an overall performance estimate. 
High scores on number of hits indicating more accurate identification, 
while high scores on false alarms indicating less accurate identification 
were examined as secondary outcomes. High scores on d′, therefore, 
indicated a greater ability to distinguish signal from noise. d′ data were 
available for n = 3242 participants. 
2.2.6. Response inhibition 
The Stop Signal Task (Logan et al., 1984) was used to assess response 
inhibition – the ability to prevent an ongoing motor response. The task 
consisted of 256 trials, which included a 4:1 ratio of trials without stop 
signals to trials with stop signals. Mean response times were calculated. 
An estimate of stop signal reaction time (SSRT) was calculated using the 
median of the inhibition function approach (Band et al., 2003). SSRT 
used as the primary outcome as it is a reliable measure of inhibitory 
control, with shorter reaction times indicating faster inhibition. SSRT 
data were available for 3201 participants. Individual Stop Signal indices 
(i.e., Go reaction time, Stop accuracy, and Go accuracy) were examined 
as secondary outcomes. 
2.2.7. Emotion recognition 
Emotion recognition was assessed using a six alternative forced 
choice (6AFC) emotion recognition task (Penton-Voak et al., 2012) 
comprising of 96 trials (16 for each emotion) which measures the ability 
to identify emotions in facial expressions that vary in intensity. In each 
trial, participants were presented with a face displaying one of six 
emotions: anger, disgust, fear, happiness, sadness, or surprise. Partici-
pants were required to select the descriptor that best described the 
emotion that was present in the face, using the computer mouse. 
Emotion intensity varied across 8 levels within each emotion from the 
prototypical emotion to an almost neutral face. Each individual stimulus 
was presented twice, giving a total of 96 trials. An overall measure of 
emotion recognition (the number of facial emotions accurately identi-
fied) was used as the primary outcome. Emotion recognition data were 
available for n = 3368 participants. Each of the individual emotions 
were examined as secondary outcomes. 
2.2.8. Potential confounders 
Confounders comprised of established risk factors for cognitive 
functioning that could plausibly have a relationship with earlier sub-
stance use. Potential confounders included: income, maternal education, 
socioeconomic position, housing tenure, sex, and maternal smoking 
during first trimester in pregnancy. Working memory at approximately 
11 years and experience of a head injury/unconsciousness up to 11 years 
were included to control for cognitive functioning prior to baseline 
measures of substance use. Finally, a measure of alcohol use asking 
whether they had ever had a whole drink of alcohol was collected at age 
13 years (up to the first assessment of smoking and cannabis use). 
Further information is presented in Supplementary Material. 
2.3. Statistical methods 
Different tobacco and cannabis phenotypes were used across 
different analytic methods. 
2.3.1. Observational analyses 
Tobacco and cannabis class membership was related to covariates 
using the Bolck-Croon-Hagenaars (Bolck et al., 2004) method. This 
approach uses the weights derived from the latent classes to reflect 
measurement error in the latent class variable. Linear regression was 
used to examine the association between the cognitive outcomes and 
latent class membership controlling for the confounding variables. Re-
sults are reported as unstandardized beta coefficients with 95 % confi-
dence intervals. Analyses were carried out using Mplus 8.4 (Muthén and 
Muthén, 2016). 
2.3.2. Missing data 
Missing data was dealt with in three steps. First, full information 
maximum likelihood (FIML) was used to derive trajectories tobacco (n =
8525) and cannabis (n = 8093) based on individuals who had infor-
mation on at least one timepoint between 13 and 18 years. For a detailed 
description of missingness at each timepoint see Tables S2a and S2b. 
Next, multiple imputation was based on 3232 participants (for both 
tobacco and cannabis models) who had information on at least one of 
the cognitive outcomes. The imputation model (based on 100 datasets) 
contained performance on all of the cognitive tasks, all measures of 
tobacco and cannabis use, and potential confounding variables, as well 
as a number of auxiliary variables known to be related to missingness (e. 
g., substance use in early adolescence, parental financial difficulties, and 
other SES variables). Finally, inverse probability weighting was used 
where estimates of prevalence and associations were weighted to ac-
count for probabilities of non-response to attending the clinic. See 
Table S3 for a detailed description of attrition for completing the 
cognitive assessments at age 24 years. See Tables S4a and S4b for a 
detailed description of confounding factors associated with tobacco and 
cannabis use class membership. See Table S5 for a detailed description of 
sample characteristics. 
2.3.3. Genetic analyses 
Our aim was to triangulate the findings from the observational an-
alyses with one- and two-sample MR analyses. However, due to insuf-
ficient power in the two-sample MR analyses, we will primarily focus on 
the one-sample MR results. Two-sample MR are still included as a set of 
sensitivity analyses as they allow us to conduct some of the pleiotropy 
robust methods (e.g., MR-Egger, weighted median, and weighted mode), 
but must be interpreted with caution. Information on genotyping and 
quality control are presented in the Supplementary Material. 
2.3.4. Mendelian randomization (MR) 
One-sample MR analyses using two-stage least squares regression 
models with robust standard errors was used to examine the to examine 
the polygenic risk score constructed using genome-wide significant SNPs 
for smoking initiation (378 SNPs (Liu et al., 2019) as an instrument for 
smoking initiation and cannabis use (8 SNPs (Pasman et al., 2018) as an 
instrument for lifetime cannabis use in relation to the three cognitive 
assessments at 24 years of age. Using individual-level data, the first stage 
involves regressing tobacco/cannabis use upon SNPs for individual 
smoking initiation/lifetime cannabis use. Lifetime tobacco use (n =
1638/5107) (32 %) up to age 15 years and lifetime cannabis use (n =
1348/5319) (25 %) up to age 24 years were chosen as exposures. Each of 
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the cognitive outcomes were then regressed on the fitted values from the 
stage 1 for tobacco and cannabis use in the second stage. The three key 
assumptions in MR are 1) the genetic instrument is robustly associated 
with the exposure of interest; 2) confounders of the exposure-outcome 
association are not associated with the genetic instrument; and 3) the 
genetic instrument is not associated with the outcome other than 
through its association with the exposure; see (Lawlor et al., 2017) for a 
full description. Power calculations conducted for one-sample MR ana-
lyses using mRnd (Brion et al., 2012) indicated that we had 80 % power 
to detect an effect size of 0.24 for smoking initiation and 0.15 for life-
time cannabis use using a sample size of n~3300 (individuals who had 
available cognitive data in ALSPAC). 
2.3.5. Sensitivity analyses 
Two-sample MR analysis was used to test the hypothesised causal 
effect of smoking initiation and lifetime cannabis use on cognitive 
functioning. See Supplementary material for further details. 
3. Results 
3.1. Observational analyses 
3.1.1. Patterns of tobacco use 
Fully adjusted associations between patterns of tobacco use from 
13–18 years and cognitive functioning outcomes at age 24 are presented 
in Table 1. There was evidence to suggest that late-onset regular tobacco 
smokers demonstrated poorer working memory performance (b=-0.29, 
95 %CI=-0.45 to -0.13) and emotion recognition (b=-0.02, 95 %CI=- 
0.03 to -0.00) compared to non-tobacco users. While early-onset regular 
tobacco smokers showed poorer performance across all three cognitive 
outcomes compared to the non-tobacco users: working memory (b=- 
0.45, 95 %CI=-0.84 to -0.05), response inhibition (b = 0.18, 95 %CI =
0.07 to 0.28), and emotion recognition (b=-0.04, 95 %CI=-0.08 to 
-0.01). All associations were supported by significant Wald test values 
indicating a significant difference between the groups. Results demon-
strating various levels of adjustment are presented in the Supplementary 
Material (Tables S6a-S6c). 
In the secondary analyses, there was some evidence to suggest that 
early-onset regular tobacco smoking was associated with fewer correct 
hits on the N-back task in the fully adjusted models (Table S7). There 
was evidence to suggest that late-onset regular tobacco users were 
associated with poorer Go and Stop accuracy in the fully adjusted 
models (Table S8). There was some evidence to suggest late-onset reg-
ular tobacco users had poorer ability to identify ‘fear’ and ‘surprise’, 
while early-onset regular tobacco users had poorer ability to identify 
‘sad’ in the fully adjusted models (Table S9d). 
3.1.2. Patterns of cannabis use 
Fully adjusted associations between patterns of cannabis use from 
13–18 years and cognitive functioning outcomes at age 24 are presented 
in Table 2. There was evidence to suggest that early-onset regular 
cannabis users showed poorer working memory performance (b=-0.62, 
95 %CI=-0.93 to -0.31) and response inhibition (b = 0.30, 95 %CI =
0.08 to 0.52) compared to non-cannabis users. All associations were 
supported by significant Wald test values indicating a significant dif-
ference between the groups. Results demonstrating various levels of 
adjustment are presented in the Supplementary Material (Tables S10a- 
10c). 
In the secondary analyses, there was evidence to suggest that early- 
onset cannabis users were associated with worse Go and Stop accuracy 
compared to non-cannabis users, in the fully adjusted models 
(Table S11). There was no evidence of an association between specific 
response inhibition measures in the sensitivity analyses (Table S12). 
Early- and late-onset occasional cannabis users had better ability to 
identify ‘anger’ and ‘disgust’, while late-onset occasional cannabis users 
had poorer ability to identify ‘happy’ in the fully adjusted models 
(Table 13d). 
3.2. Genetic analyses 
Information testing whether the genetic instruments are associated 
with the confounders are presented in the Supplementary Material 
(Tables S14a and S14b). 
3.2.1. One-sample Mendelian randomization 
Results from the one-sample MR provided little evidence to suggest 
that smoking initiation or lifetime cannabis use were causal risk factors 
for deficits in cognitive functioning (Table 3). SNPs associated with 
smoking initiation were not associated with working memory (b=-0.38, 
95 %CI=-1.51 to 0.75; p = 0.51); response inhibition (b=-0.27, 95 % 
CI=-1.31 to 0.77; p = 0.61); or emotion recognition (b=-0.53, 95 %CI=- 
1.59 to 0.53; p = 0.33). Similarly, SNPs associated with lifetime cannabis 
use were not associated with working memory (b=-1.41, 95 %CI=-3.31 
to 0.49; p = 0.14); response inhibition (b = 0.02, 95 %CI=-1.31 to 1.35; 
p = 0.98); or emotion recognition (b=-0.04, 95 %CI=-1.35 to 1.27; p =
0.95). 
3.2.2. Sensitivity analyses 
Overall, the two-sample MR methods provided some evidence to 
suggest that SNPs associated with smoking initiation and SNPs associ-
ated with lifetime cannabis use were a causal risk factor for deficits in 
cognitive functioning. See Supplementary Material (Tables S15a and 
S15b). 
4. Discussion 
This observational study provided evidence to suggest an association 
between tobacco and cannabis use across adolescence and subsequent 
cognitive functioning. Early- and late-onset regular tobacco smokers 
demonstrated poorer working memory and poorer ability to recognise 
emotions; while, early-onset regular tobacco smokers had slower ability 
to inhibit responses compared to non-tobacco smokers. Early-onset 
regular cannabis users had poorer working memory performance and 
slower ability to inhibit responses compared to non-cannabis users. Our 
results remained largely consistent when controlling for prior measures 
Table 1 
Smoking patterns from 13 to 18 years and cognitive functioning at age 24 (fully 








n = 3232 for 
all models 















































Note. Models adjusted for socioeconomic status, working memory at age ~11 
years; head injury/ unconsciousness up to age 11 years, and alcohol use before 
13 years of age; Wald tests determine whether there were differences between 
patterns of tobacco use and subsequent cognitive functioning; Working memory: 
negative d’ scores reflect poorer performance; Response inhibition: longer re-
action times reflect poorer performance; Emotion recognition: negative scores 
reflect poorer performance. 
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of substance use and cognition allowing for clear temporality between 
exposure and outcomes. Genetic analyses were imprecise and did not 
provide sufficient evidence for a possible causal association between 
smoking initiation and lifetime cannabis use and cognitive functioning 
in the ALSPAC sample. It is likely that these analyses were 
underpowered. 
4.1. Comparison with previous studies 
To our knowledge, this is the first study to assess the relationship 
between separate tobacco and cannabis use in adolescents, and subse-
quent cognitive functioning using a combination of observational and 
genetic epidemiological approaches. Overall, we found an adverse as-
sociation between tobacco/cannabis use and working memory, response 
inhibition, and emotion recognition in ALSPAC. Those who initiated 
regular use at earlier and later ages demonstrated poorer performance 
on the cognitive tasks. There was some evidence to suggest cannabis use 
with associated with emotion-specific impairments in emotion recog-
nition. This is in line with previous research suggesting cannabis users 
may have poorer recognition of negative emotions (Bossong et al., 
2013). Our results also tentatively suggest that recognition deficits may 
be related to specific patterns of cannabis use, with different patterns in 
early- and late-onset use. The observational findings contribute to a 
literature of mixed findings regarding the direction of association be-
tween tobacco and cannabis exposure and subsequent cognition by 
suggesting that adolescent tobacco and cannabis use precede observed 
reductions in cognitive function. These findings support studies that 
have demonstrated effects may depend on the frequency, duration, and 
age at onset of use (Boccio and Beaver, 2017; Castellanos-Ryan et al., 
2017; Fontes et al., 2011; Mashhoon et al., 2018; Meier et al., 2018; 
Mokrysz et al., 2016a). 
Our study extends previous findings in a number of ways. First, the 
observational study was better powered than most of the previous 
studies as it used data from over 3200 participants providing informa-
tion spanning birth to 24 years of age. Second, identifying heteroge-
neous patterns of tobacco and cannabis use across this crucial period 
allows individuals who follow markedly different developmental tra-
jectories to be captured (Chen and Kandel, 1995; Degenhardt et al., 
2008). Third, the cognitive measures were assessed at a time when they 
are expected to have reached maturity in some individuals (Davidson 
et al., 2006; Fry and Hale, 2000; Kramer et al., 2005; Thomas et al., 
2007), in comparison to previous studies which have examined cogni-
tive functioning at earlier ages while they are still maturing. Examining 
mature levels of cognitive functioning reduces the possibility that 
cognitive functioning is influencing earlier tobacco and cannabis use, 
effects that cannot be disentangled in purely cross-sectional studies. 
Further, our ability to control for earlier measures of cognitive func-
tioning and substance use, prior to the baseline measures of tobacco and 
cannabis use helps to rule out the possibility of reverse causation. 
Fourth, our study sought to examine specificity in cognitive functioning, 
by using well-validated tests to probe different domains of cognitive 
functioning instead of focusing on general intelligence. Finally, we 
sought to triangulate our results by using one- and two-sample MR ap-
proaches to assess tobacco and cannabis use as causal risk factors for 
cognitive functioning. This approach can help to overcome the main 
sources of bias from classical observational approaches, by providing a 
more reliable estimate of the likely underlying causal relationship. 
4.2. Limitations 
There are limitations to this study that should be considered. First, 
the ALSPAC cohort suffers from attrition, which is higher among the 
socially disadvantaged (Wolke et al., 2009). Furthermore, polygenic 
scores for tobacco smoking initiation were associated with drop out in 
the ALSPAC (Taylor et al., 2018). We attempted to minimize the effect of 
drop-out by using multiple imputation, FIML, and inverse probability 
weighting which assume MAR missing patterns. Although it is not 
possible to test the MAR assumption, it was made more plausible as a 
number of SES variables were found to predict whether participants 
attended the clinic or not (Table S1). Second, tobacco and cannabis use 
were self-reported. However, there is evidence to suggest that 
self-reported assessments are reliable and valid methods (Boykan et al., 
2019), and the assessment of tobacco and cannabis use yearly over 6 
years in a latent variable framework helps to account for measurement 
error (Bray et al., 2015). Third, while the longitudinal approach for each 
substance used in this study has a number of advantages over using 
measures at a single timepoint, it was not possible to examine cannabis 
use without tobacco use as most cannabis users use cannabis in combi-
nation with tobacco (Amos et al., 2004). We therefore cannot rule out 
the possibility that observed associations between cannabis use and 
cognitive functioning are exacerbated by the combined use of cannabis 
and tobacco. Fourth, different measures of tobacco and cannabis use for 
the observational and MR analyses were used. Along with deriving 
latent classes of tobacco and cannabis use, we used the largest GWAS 
consortia (GSCAN) which has identified 341 genetic instruments for 
‘smoking initiation’, and the GWAS conducted by Pasman and col-
leagues which identified 8 genetic instruments for lifetime cannabis use 
which are continuous measures. To our knowledge it is not currently 
possible to use a nominal exposure (as was used in the observational 
analyses) and consequently the effect sizes are not directly comparable. 
Fifth, it is likely that both the one- and two-sample MR analyses are 
Table 2 
Patterns of cannabis use from 13 to 18 years and cognitive functioning at age 24 (fully adjusted models).   
Non-user Late-onset occasional Early-onset occasional Early-onset regular  
n = 3232 for all models Reference b (95% CI) b (95% CI) b (95% CI) Wald (df) p value 
Working memory – − 0.10 (-0.22, 0.03) 0.12 (-0.17, 0.41) − 0.62 (-0.93, -0.31) 18.56 (3) p < 0.001 
Response inhibition – 0.04 (-0.04, 0.11) 0.05 (-0.11, 0.22) 0.30 (0.08, 0.52) 9.24 (3) p = 0.02 
Emotion recognition – − 0.00 (-0.01, 0.01) 0.02 (-0.00, 0.05) − 0.02 (-0.05, 0.01) 4.23 (3) p = 0.24 
Note. Models adjusted for socioeconomic status, working memory at age ~11 years; head injury/ unconsciousness up to age 11 years, and alcohol use before 13 years 
of age; Wald tests determine whether there were differences between patterns of tobacco use and subsequent cognitive functioning; Working memory: negative d’ 
scores reflect poorer performance; Response inhibition: longer reaction times reflect poorer performance; Emotion recognition: negative scores reflect poorer 
performance. 
Table 3 
One-sample MR analyses of the effects of smoking initiation on cognitive func-
tioning (standardised coefficients).  
N = 1638 β se 95 %CI p F statistic 
Smoking initiation      
Working memory − 0.38 0.58 − 1.51, 0.75 0.51 14.63 
Response inhibition − 0.27 0.53 − 1.31, 0.77 0.61 18.12 
Emotion recognition − 0.53 0.54 − 1.59, 0.53 0.33 17.57  
Lifetime cannabis use 
N = 1348      
Working memory − 1.41 0.97 − 3.31, 0.49 0.14 6.70 
Response inhibition 0.02 0.68 − 1.31, 1.35 0.98 8.87 
Emotion recognition − 0.04 0.69 − 1.35, 1.27 0.95 8.79  
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underpowered. However, findings using weak instruments tend to bias 
findings towards the null in the two-sample setting and toward the 
outcome-risk association in the one-sample setting (Davies et al., 2018). 
Sixth, the main limitation of one- and two-sample MR is that the quality 
of the pooled results in the GWAS consortia is dependent on the indi-
vidual studies. Another limitation is that the same sample may 
contribute to both GWAS (i.e., GWAS for exposure and outcome) which 
was the case in the current study as ALSPAC was in both the exposure 
and outcome. This will bias the MR estimate towards the observed es-
timate. However, as the MR found no clear evidence for an effect, this 
suggests it was not biased by overlapping samples. See Lawlor and 
colleagues (Lawlor et al., 2017) for a more comprehensive description of 
limitations associated with MR studies. Finally, it is possible that the 
direction of the association could work in both ways, that is, impair-
ments in cognitive functioning may precede (and increase the risk of 
developing) tobacco and cannabis use (Anokhin and Golosheykin, 2016; 
Castellanos-Ryan et al., 2017; Cousijn et al., 2014). We were able to 
include a number of measures to maximize the robustness of our find-
ings: (i) ascertaining the temporal order of exposures and outcomes; (ii) 
controlling for premorbid working memory and brain insults prior to 
measures of tobacco/cannabis use helped to reduce the possibility of 
cognitive impairments, or lower cognitive abilities in childhood, influ-
encing tobacco/cannabis use; and (iii) it is possible that a common risk 
factor is influencing both tobacco/cannabis use and lower cognitive 
function, however MR methods helps to protect against this possibility 
by minimizing bias from reverse causation and residual confounding. 
4.3. Implications and conclusions 
Overall, there was observational evidence that adolescent tobacco 
and cannabis use were associated with subsequent cognitive func-
tioning, highlighting impairments in a range of cognitive domains, 
including working memory, response inhibition and emotion recogni-
tion. Our findings lend support to the developmental vulnerability hy-
pothesis, in that, tobacco and cannabis use in adolescence, when the 
brain is undergoing critical development, may have neurotoxic effects. 
Better powered genetically informed studies are required to determine 
whether these associations are causal. In order to rule out the possibility 
of deficient cognitive functioning preceding substance in adolescence, 
future research should use an equally robust approach to examine the 
alternate hypothesis. This study lends support to public health strategies 
and interventions aimed at reducing tobacco and cannabis exposure in 
young people. 
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